# AstraZeneca Pharmaceuticals LP – FDA Inspection, Sep 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f66f66c2-0f6a-4aa1-972a-c17574142886
Source feed: FDA_Inspections

> FDA inspection 1218331 of AstraZeneca Pharmaceuticals LP, September 19, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218331
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2023-09-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 965123 - 2016-01-28
- FDA Inspection 853863 - 2013-10-25
- FDA Inspection 798609 - 2012-09-13
- [FDA Inspection 751470 - 2011-10-28](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/5d401b01-20f7-49dd-b629-fc4aeae2f2cf)
- FDA Inspection 741276 - 2011-08-12

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/joseph-a-piechocki/1977a57b-4976-4b01-b8da-66a84b26e803)

Company: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c